The US Government's Financial Support to Push Comparative Effectiveness Research

GlobalData

- Pub ID: GBDT2474912

Countries covered: United States

Summary

GlobalData's new report - "The US Government’s Financial Support to Push Comparative Effectiveness Research", explores the US medical equipment industry and the intricacies of the economic stimulus bill. The US Congress in the early part of 2009 made available $1.1 billion in funds for comparative effectiveness research as part of its economic stimulus program. The main goal of comparative effectiveness research is to bring down the costs of drugs, devices and treatments and make them available to all the patients. Comparative effectiveness research provides relative positives and negatives of different treatment options for the same disease condition. Such research provides physicians and patients with information on which to base their clinical decisions.

The healthcare industry and patients alike contend that cost alone shouldn’t be the only criteria in deciding the treatment options for patients. Research may help save costs in the short term but eventually in the long run the costs are going to escalate further as patients do not receive the right treatment for their medical condition. Decisions should be based on overall effectiveness of a drug, device or treatment rather than on cost alone. Imposition of cost constraints may lead to worse patients' conditions and more importantly increases the healthcare costs in the long term.

Comparative effectiveness research needs to expand its focus to studies that encompass all aspects of the health care delivery system rather than just concentrating on drugs, biologics and devices. The research should include preventative services, emergency response and diagnostic tests to reflect the various components of the overall healthcare delivery system.

Scope

Insights into the medical equipment industry in the US
Analysis of government initiatives and incentives such as economic stimulus program as part of the healthcare reforms
Review of key factors of the economic stimulus package and the effect on the US medical equipment industry

Reasons to buy

Develop business strategies with the help of specific insights from GlobalData on key events within the medical equipment industry.
Gain a strong understanding and analyze goverment initiatives in the US medical equipment industry
Identify growth opportunities and possible challenges expected to emergy within the medical equipment industry in the US due to the government financial reforms

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: Monday - Thursday: 3:00am - 7:00pm eastern time

Fridays: 3:00am - 6:00pm eastern time